Home
Conditions
Necrobiotic Disorders

Clinical trial condition

Necrobiotic Disorders

Explore clinical trials studying Necrobiotic Disorders. Study availability and eligibility vary by location and protocol.

11 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Necrobiotic Disorders trial results

Recruiting

International Rare Histiocytic Disorders Registry (IRHDR)

NCT02285582

Conditions: ALK-positive Histiocytosis, Collagen Diseases, Connective Tissue Diseases, +27 more
Locations: The University of Alabama at Birmingham Birmingham, Alabama, United States

Children's Hospital of Los Angeles Los Angeles, California, United States

Valley Children's Hospital Madera, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View all 15 locations

View Trial Details

Completed

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

NCT07428954

Conditions: Acne, Acne Vulgaris, Acneiform Eruptions, +53 more
Locations: AI Labs Group S.L. Bilbao, Basque Country, Spain

View Trial Details

Completed

Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare

NCT05580042

Conditions: Collagen Diseases, Connective Tissue Diseases, Granuloma, +6 more
Locations: Yale Center for Clinical Investigation New Haven, Connecticut, United States

View Trial Details

Completed

Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy

NCT00720980

Conditions: Collagen Diseases, Connective Tissue Diseases, Granuloma, +6 more
Locations: Henry Ford Medical Center Detroit, Michigan, United States

View Trial Details

Completed

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

NCT04492618

Conditions: Collagen Diseases, Connective Tissue Diseases, Metabolic Diseases, +6 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica

NCT03698864

Conditions: Collagen Diseases, Connective Tissue Diseases, Metabolic Diseases, +6 more
Locations: Processa Investigational Site Philadelphia, Pennsylvania, United States

Processa Investigational Site Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Evaluation of 41 Cases of Pediatric Granuloma Annulare

NCT05472636

Conditions: Collagen Diseases, Connective Tissue Diseases, Granuloma, +6 more
Locations: Istanbul Training and Research Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Open-label Trial of Tofacitinib in Cutaneous Sarcoidosis and Granuloma Annulare

NCT03910543

Conditions: Collagen Diseases, Connective Tissue Diseases, Cutaneous Sarcoidosis, +7 more
Locations: Yale Center for Clinical Investigation New Haven, Connecticut, United States

View Trial Details

Completed

Pain Outcomes Following Intralesional Corticosteroid Injections

NCT03630198

Conditions: Acne, Acne Vulgaris, Acneiform Eruptions, +41 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix

NCT00129428

Conditions: Acne Keloid, Acne Keloidalis, Acneiform Eruptions, +18 more
Locations: University of Michigan Department of Dermatology Ann Arbor, Michigan, United States

View Trial Details

Necrobiotic Disorders

Necrobiotic Disorders trial results

Related conditions